Skip to content

Mahana Tinnitus Pilot

A Prospective, Open-Label Trial of MHNA-003, a Smartphone-Delivered Cognitive Behavioral Therapy (CBT) Treatment, in Adults With Symptoms of Tinnitus

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05696158
Enrollment
97
Registered
2023-01-25
Start date
2022-12-19
Completion date
2023-08-02
Last updated
2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Tinnitus

Brief summary

The main objective of this prospective, open-label, non-significant risk study is to assess the efficacy and safety of Mahana™ Tinnitus together with care as usual in approximately 250 adults with symptoms of tinnitus.

Detailed description

Following informed consent, all participants will complete a series of screening questionnaires to determine eligibility for study entry. Eligible participants will be enrolled, and will receive access to MHNA-003 (Mahana™ Tinnitus). Participants will use MHNA-003 for 6 weeks, completing assessments at Baseline and Weeks 2, 4, and 6 following Baseline.

Interventions

DEVICEMHNA-003

MHNA-003 is a self-guided digital program for people living with tinnitus

Sponsors

Mahana Therapeutics
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Participant scores ≥ 25 on the Tinnitus Functional Index. * Participant has experienced symptoms of tinnitus for at least 3 months. * Participant is at least 18 years of age at the time of consent. * Participant resides in the United States. * Participant is able to speak, read, and understand English. * Participant has access to an iOS or Android smartphone with the ability to complete study tasks. * Participant is able to commit the time required to complete therapy modules and study assessments.

Exclusion criteria

* Participant scores ≥2 on item 9 (suicidal thoughts) of the Beck's Depression Index (BDI). * Participant has been hospitalized for psychiatric reasons within 12 months of screening. * Participant is currently enrolled in or plans to enroll in another clinical study that could impact outcomes of this trial.

Design outcomes

Primary

MeasureTime frameDescription
Mean Change in TFI Score From Baseline to Week 66 weeksThe Tinnitus Functional Index (TFI) is a validated, 25-item questionnaire designed to measure the severity and negative impact of tinnitus. Total scores range from 0-100 with higher scores representing higher severity and more negative impact. An improvement of 13 or more points is considered a clinically meaningful change.
Tinnitus Functional Index Responder Rate6 weeksThe Tinnitus Functional Index (TFI) is a validated, 25-item questionnaire designed to measure the severity and negative impact of tinnitus. Total scores range from 0-100 with higher scores representing higher severity and more negative impact. A responder is defined as a participant who experienced an improvement of 13 or more points from baseline to Week 6. The responder rate is the percentage of participants considered responders at Week 6.

Countries

United States

Participant flow

Participants by arm

ArmCount
MHNA-003
MHNA-003 is a self-guided digital program for people living with tinnitus
97
Total97

Baseline characteristics

CharacteristicMHNA-003
Age, Continuous56.84 years
STANDARD_DEVIATION 12.1
Ethnicity (NIH/OMB)
Hispanic or Latino
9 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
88 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants
Race (NIH/OMB)
American Indian or Alaska Native
1 Participants
Race (NIH/OMB)
Asian
6 Participants
Race (NIH/OMB)
Black or African American
3 Participants
Race (NIH/OMB)
More than one race
0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
Race (NIH/OMB)
Unknown or Not Reported
2 Participants
Race (NIH/OMB)
White
85 Participants
Region of Enrollment
United States
97 participants
Sex: Female, Male
Female
58 Participants
Sex: Female, Male
Male
39 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 97
other
Total, other adverse events
0 / 97
serious
Total, serious adverse events
0 / 97

Outcome results

Primary

Mean Change in TFI Score From Baseline to Week 6

The Tinnitus Functional Index (TFI) is a validated, 25-item questionnaire designed to measure the severity and negative impact of tinnitus. Total scores range from 0-100 with higher scores representing higher severity and more negative impact. An improvement of 13 or more points is considered a clinically meaningful change.

Time frame: 6 weeks

Population: Intent to treat population

ArmMeasureValue (MEAN)Dispersion
MHNA-003Mean Change in TFI Score From Baseline to Week 6-20.50 score on a scaleStandard Error 1.86
Primary

Tinnitus Functional Index Responder Rate

The Tinnitus Functional Index (TFI) is a validated, 25-item questionnaire designed to measure the severity and negative impact of tinnitus. Total scores range from 0-100 with higher scores representing higher severity and more negative impact. A responder is defined as a participant who experienced an improvement of 13 or more points from baseline to Week 6. The responder rate is the percentage of participants considered responders at Week 6.

Time frame: 6 weeks

Population: Intent to treat

ArmMeasureValue (NUMBER)
MHNA-003Tinnitus Functional Index Responder Rate61.3 percentage of responders

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026